|
Market Closed -
Sao Paulo
00:23:53 05/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 79.85 BRL | +3.33% |
|
+12.80% | +39.28% |
| 11-04 | DZ Bank Adjusts Price Target on Gilead Sciences to $191 From $167 | MT |
| 11-02 | Dr Reddy's gets tentative US FDA nod for generic HIV prevention | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.61% | +10.62% | +24.07% | +26.45% | +31.95% | +58.16% | +149.73% | +432.56% | +1,866.43% | 1,255B | |
| +3.81% | +2.82% | +7.92% | +8.61% | +33.52% | +48.35% | +82.58% | +67.41% | +140.22% | 641B | |
| +3.09% | +2.95% | +12.18% | +20.29% | +29.03% | +39.10% | +108.48% | +150.77% | +427.52% | 505B | |
| +1.25% | -0.78% | +14.52% | +11.21% | +20.63% | +52.56% | +66.87% | +7.44% | +77.77% | 381B | |
| +3.93% | +6.02% | +4.20% | +17.68% | +42.85% | +82.28% | +45.44% | +69.55% | +157.33% | 357B | |
| +2.10% | +4.26% | +15.40% | +7.84% | +22.50% | +34.93% | +61.10% | +75.57% | +94.72% | 303B | |
| +1.92% | +9.37% | +18.15% | +21.95% | +1.70% | +13.43% | +36.55% | +50.15% | +216.25% | 286B | |
| +3.73% | +6.82% | +18.72% | +26.29% | +46.19% | +61.48% | +77.31% | +119.36% | +253.85% | 249B | |
| +4.19% | +9.68% | +20.55% | +33.04% | +42.15% | +42.96% | +113.85% | +158.83% | +143.14% | 208B | |
| +5.57% | +9.90% | +14.65% | -5.66% | -12.31% | -9.55% | -58.30% | -22.03% | +140.88% | 179B | |
| +2.63% | +3.32% | +10.76% | +23.01% | +23.65% | +24.86% | -1.50% | -31.30% | +3.01% | 171B | |
| +3.44% | +5.38% | +8.78% | +16.64% | +21.10% | +28.88% | +45.94% | +190.39% | +606.71% | 135B | |
| +4.02% | +4.29% | +4.97% | -1.96% | +19.00% | +39.48% | +21.53% | +8.14% | +27.84% | 126B | |
| +6.98% | +10.59% | +18.53% | +29.29% | +30.37% | +30.37% | +136.20% | +376.94% | +725.25% | 117B | |
| +3.85% | +11.91% | +18.77% | +12.89% | +1.67% | -3.27% | -1.46% | -6.80% | +16.34% | 109B | |
| +3.42% | -1.74% | +6.21% | -1.02% | +3.59% | +7.57% | +35.43% | -3.73% | -2.70% | 98.3B | |
| -4.39% | +14.04% | +26.59% | +22.58% | +20.57% | +44.91% | +13.93% | +42.72% | +176.98% | 97.67B | |
| +13.11% | +24.24% | +35.98% | +368.59% | +776.16% | +937.25% | +233.26% | -25.31% | - | 91.2B | |
| +0.87% | +4.12% | +9.90% | +5.62% | +22.72% | +34.63% | +2.80% | -29.47% | +62.95% | 72.58B | |
| Average | +1.85% | +3.90% | +15.31% | +33.86% | +61.95% | +82.55% | +61.57% | +85.85% | +285.25% | 283.18B | |
| Weighted average by Cap. | +1.37% | +4.01% | +15.79% | +23.70% | +39.51% | +59.39% | +83.55% | +157.98% | +593.12% |
- Stock Market
- Stocks
- GILD Stock
- GILD34 Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
